Azithromycin and lower respiratory tract infections.

@article{Blasi2005AzithromycinAL,
  title={Azithromycin and lower respiratory tract infections.},
  author={Francesco Blasi and Mario Cazzola and Paolo Tarsia and Roberto Cosentini and Stefano Aliberti and Pierachille Santus and Luigi Allegra},
  journal={Expert opinion on pharmacotherapy},
  year={2005},
  volume={6 13},
  pages={2335-51}
}
Azithromycin is a macrolide antibiotic that has been structurally modified from erythromycin with an expanded spectrum of activity and improved tissue pharmacokinetic characteristics relative to erythromycin. This allows once-daily administration for 3-5 days of treatment compared with traditional multi dosing 7-10-day treatment regimens. It has been successfully employed in lower respiratory tract infections. Recent data indicate that azithromycin may exert anti-inflammatory/immunomodulatory… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…